NTL Healthcare, an AI femtech company specialized in women's health, announced that it participated

in the Korean Society of Obstetrics and Gynecology's Spring Conference held on April 7th and April 14th.

 

 

NTL Healthcare, which occupies over 80% of the domestic market for cervical cancer screening,

received a warm response from more than 1,500 obstetricians and gynecologists at the conference

for introducing the CerviCARE AI®, an artificial intelligence cervical cancer screening system,

as well as the world's first feminine cleanser, iner:y NK, which contains human blood derived natural killer (NK) cell conditioned media extract.

 

 

HPV (human papillomavirus), a major cause of cervical cancer, has a characteristic of being expressed

when the immune system is weakened, so it is known that it is important to enhance the immune system against the virus,

but until now, there has been no special alternative but to wait for natural healing.

 

 

iner:y NK® is an HPV feminine cleanser that includes human blood derived NK cell conditioned media extract,

which is a patented technology that separates, activates, and cultures specific immune cells through a cell separation system

from peripheral blood collected from the human body. It is registered in the International Cosmetic Ingredient Dictionary (ICID)

as the first HPV feminine cleanser to meet the strict regulations of the Korea Food and Drug Administration (KFDA)

for toxicity testing, safety testing, and immune response testing. It has exploded in popularity,

being used by more than 200 obstetrics and gynecology clinics within 2 months of its launch.

 

 

NTL Healthcare is working with ImmuneBio, a leading company in the field of immunotherapy using NK immune cells,

to develop anti-cancer therapies, including cervical cancer, using immune cell cancer therapy.